Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,833–2,840 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Moleculin Biotech Inc. Annamycin (MB-106) in combination with Cytarabine - (Ara-C, MIRACLE) Acute Myeloid Leukemia (AML) Phase 3 Enrollment Initiation Intravenous Oncology
Moleculin Biotech Inc. WP1066 Pediatric Recurrent Malignant Brain Tumors Phase 2 Trial Planned Oral Oncology
Moleculin Biotech Inc. WP1066 Pediatric Recurrent Malignant Brain Tumors Phase 2 Trial Planned Oral Oncology
Moleculin Biotech Inc. WP1066 Glioblastoma (NU 21C06) Phase 2 Ongoing Oral Oncology
Moleculin Biotech Inc. WP1066 Recurrent Malignant Glioma Phase 2 Ongoing Oral Oncology
Monopar Therapeutics Inc. ALXN1840 (WTX101) - (FoCus) Wilson disease Phase 3 Data Released Oral Genetic Disorder
Monopar Therapeutics Inc. ALXN1840 (WTX101) - (FoCus) Wilson disease Phase 3 Data Released Oral Genetic Disorder
Monopar Therapeutics Inc. Validive - (VOICE) Oral mucositis Phase 2/3 Trial Discontinued Buccal Wound Care